Search

Thousands of oncology experts from around the world will tune in May 29-31 for the American Society of Clinical Oncology’s (ASCO) Virtual Scientific Program. MSK physicians and scientists are involved in notable research to be presented at the meeting.

… Wednesday, May 27, 2020 Thousands of oncology experts from around the world will tune in May 29-31 for the American Society of Clinical Oncology’s (ASCO) Virtual Scientific Program . The online meeting will provide an engaging lineup of scheduled and on-demand scientific content including a plenary session

The FDA has granted full approval to the targeted therapy selpercatinib (Retevmo®) for treating thyroid cancers that have certain changes in a gene called RET. Learn about MSK’s role in the development of this drug and about how patients may benefit.

… Wednesday, July 10, 2024 On June 12, 2024, the US Food and Drug Administration (FDA) granted full approval to the targeted therapy  selpercatinib (Retevmo ® ) for treating adult and pediatric patients 2 years and older with advanced or metastatic  thyroid cancers that have certain changes in a gene called

Learn more about the new FDA-approved drug repotrectinib (AugtyroTM), which targets ROS1 fusions in lung cancer and other cancer types.

… Wednesday, January 10, 2024 Ingrid Adams, now 68, has been coping with metastatic lung cancer for more than a decade. Standard treatment — including chemotherapy and radiation therapy — kept her disease under control for a while, but the cancer continued to spread. Everything changed when she came to

Obtenga más información sobre el nuevo fármaco aprobado por la FDA, repotrectinib (AugtyroTM), que ataca las fusiones de ROS1 en el cáncer pulmonar y otros tipos de cáncer.

… Wednesday, January 10, 2024 Ingrid Adams, que ahora tiene 68 años, ha estado lidiando con el cáncer pulmonar metastásico durante más de una década. El tratamiento estándar, que incluye quimioterapia y radioterapia , mantuvo su enfermedad bajo control por un tiempo, pero el cáncer continuó diseminándose

Learn what can be done for patients like Stephanie Soto-Vega who confront financial hardships caused by cancer.

… Thursday, April 10, 2025 It was hard enough for Stephanie Soto-Vega to get the news that her breast cancer had spread to her hip bones and spine. Then came another blow: Her insurance company wouldn’t cover the medication to keep the cancer under control. It cost $15,000 a month. “I was really worried

Meet a few of our brave and determined young patients who are thriving after receiving treatment at MSK.

… Friday, October 1, 2021 Ending cancer treatment is an exciting yet tricky transition for adolescents and young adults. But MSK keeps a close eye on these survivors as their physical, emotional, and social needs change over time. There are three survivorship clinics — each tailored to a specific age group

Learn more about the first facility in the world devoted to the specific needs of colorectal cancer patients under the age of 50.

… Monday, March 8, 2021 Summary A troubling rise in colorectal cancer among younger adults has led experts to advise issuing new guidelines that lower the recommended age when people should begin colorectal screenings from 50 to 45. In 2018, MSK established the first facility in the world devoted to the

Obtenga más información sobre el primer centro en el mundo dedicado a las necesidades específicas de los pacientes con cáncer colorrectal menores de 50 años.

… Monday, March 8, 2021 Resumen Un aumento preocupante de casos de cáncer colorrectal entre los adultos más jóvenes ha llevado a los expertos a sugerir que se publiquen nuevas pautas que reduzcan la edad recomendada en que las personas deben comenzar a hacerse las pruebas de detección colorrectal de los

Local control rates and overall survival (OS) were significantly higher for patients with brain metastases treated with adjuvant stereotactic radiosurgery (SRS) within two months of resection, compared to longer time intervals, according to our new study published recently in Neuro-Oncology Practice.

… Thursday, September 23, 2021 Local control rates and overall survival (OS) were significantly higher for patients with brain metastases treated with adjuvant stereotactic radiosurgery (SRS) within two months of resection, compared to longer time intervals, according to our new study published recently

A landmark study led in part by physician-researchers from Memorial Sloan Kettering is giving new hope to some people with metastatic colorectal cancer.

… Wednesday, December 23, 2020 A landmark study led in part by physician-researchers from Memorial Sloan Kettering is giving new hope to some people with metastatic colorectal cancer. In a recent issue of the  New England Journal of Medicine , results from the phase III study — Keynote 177 — provided further